|
|
|
|
Effect of Cigarette Smoking on Imatinib in Patients in the Soft Tissue and Bone Sarcoma Group of the EORTC
Van Erp N et al.- The retrospective study suggests that the pharmacokinetics of imatinib is not affected by smoking. However, smokers have an increased risk of anemia and fatigue. Effect of Cigarette Smoking on Imatinib in Patients in...
|
|
|
Teen's Cancer Battle 'An Amazing Journey'
PLANT CITY - It's a parent's worst nightmare: a child suffering a seemingly innocuous sinus infection is ultimately diagnosed with a cancer so rare, doctors worldwide report 300 or fewer new cases annually.For Plant City teen Emily Evans...
|
|
|
Stockbridge Valley student loses cancer battle
A Stockbridge Valley Central High School junior who was No.1 in her class died Saturday morning after a courageous battle with a rare form of cancer. Molly Slator, 16, died at home at 5:56 a.m. Saturday, said Stockbridge Valley...
|
|
|
[Pediatric Oncology] Soft Tissue Sarcomas of Childhood and Adolescence: The Prognostic Role of Tumor Size in R
From the Pediatric Oncology, Melanoma Sarcoma Surgery, and Pediatric Surgery Units, Pathology Department, and Division of Medical Statistics and Biometry, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto...
Journal of Clinical Oncology:
Dec 9 2008 2:36AM
Matching: rhabdomyosarcoma soft tissue sarcoma
|
Find similar documents
|
|
|
|
Press Release: Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue
SAN MARINO, Calif., Nov.25, 2008 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as...
|
|
|
Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosar
/PRNewswire/ -- Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr.Sant P. Chawla,...
|
|
|
PharmaMar gets 'Supporting A Cure In Our Time' award from SFA
PharmaMar has received the Award 'Supporting A Cure In Our Time' from the Sarcoma Foundation of America (SFA) for its 'support in the search for an effective cure for soft tissue sarcomas', goal of the foundation, during...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of...
|
|
|
Oncolytics Biotech Inc. Collaborators to Present REOLYSIN(R) Research at CTOS Annual Meeting
CALGARY, Nov.14 /CNW/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that a poster presentation authored by Dr. Anders Kolb of the Nemours Center for Childhood Cancer Research entitled 'Systemic Administration of...
|
|
|
Oncolytics Biotech Inc. Investigators Present Interim U.S. REOLYSIN(R) Phase II Sarcoma Trial Data
CALGARY, Nov.6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that an oral presentation covering the interim results of a U.S. Phase II trial investigating intravenous REOLYSIN(R) in patients...
|
